Korro to Participate in Upcoming June Investor and Scientific Conferences
Korro Bio, Inc. (KRRO)
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences: Jefferies Global Healthcare Conference Chief Executive Officer and President, Ram Aiyar, Ph.D., will present on Thursday, June 6, 2024, at 2:00 p.m. ET. Chief Financial Officer, Vineet Agarwal, will also be participating at the conference. 2024 Alpha-1 Foundation National ConferenceChief Medical Officer, Kemi Olugemo, M.D., FAAN, will discuss Korro’s lead RNA editing oligonucleotide candidate in a presentation titled, “KRRO-110, a RNA Editing Modality for the Treatment of Alpha-1 Antitrypsin Deficiency” on Saturday, June 8, 2024, at 11:20 a.m. ET. 5th Annual RNA Editing SummitSenior Vice President & Head of Platform, RNA Editing, Venkat Krishnamurthy, Ph.D., will participate in a roundtable discussion titled “Discussing Strategies for Improved Longevity of Editing Therap
Show less
Read more
Impact Snapshot
Event Time:
KRRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRRO alerts
High impacting Korro Bio, Inc. news events
Weekly update
A roundup of the hottest topics
KRRO
News
- Korro Bio, Inc. (NASDAQ: KRRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $95.00 price target on the stock.MarketBeat
- Korro Bio, Inc. (NASDAQ: KRRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.MarketBeat
- Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic CandidatesGlobeNewswire
- Korro to Participate in Upcoming Investor ConferencesGlobeNewswire
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of DirectorsGlobeNewswire
KRRO
Earnings
- 8/13/24 - Miss
KRRO
Sec Filings
- 9/16/24 - Form 424B3
- 9/16/24 - Form 424B3
- 9/16/24 - Form 8-K
- KRRO's page on the SEC website